| Hans-Günter Meyer-Thompson | Verschiedenes
'Tranq': perceptions of xylazine and harm reduction practices among people receiving treatment for substance use disorders.
'Tranq': perceptions of xylazine and harm reduction practices among people receiving treatment for substance use disorders.
Salwan A, Dowling-McClay K, Greer D, AlAli A, Brooks B.
Harm Reduct J. 2025 May 30;22(1):95. doi: 10.1186/s12954-025-01249-1. PMID: 40448143; PMCID: PMC12123732.
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-025-01249-1